Litcius/Paper detail

Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial

Suman Kanungo, Pranab Chatterjee, Ashish Bavdekar, Manoj Murhekar, Sudhir Babji, Richa Garg, Sandip Samanta, Ranjan K. Nandy, Anand Kawade, Boopathi Kangusamy, Kanagasabai Kaliaperumal, Vineet Kumar Kamal, Velusamy Saravana Kumar, Nivedita Gupta, Shanta Dutta

2022The Lancet Infectious Diseases17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRegimenRotavirus vaccineDosingRotavirusPediatricsImmunogenicityAdverse effectInternal medicineVaccinationImmunologyDiarrheaAntibodyViral gastroenteritis research and epidemiologyInfant Nutrition and HealthTransgenic Plants and Applications
Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial | Litcius